Evolent Health, Inc. (NYSE:EVH) is one of the best NYSE penny stocks to buy now. On January 7, Citi cut its price target for Evolent Health, Inc. (NYSE:EVH) to $6 from $9.50 but maintained a Buy rating, citing cautious optimism for 2026 despite a challenging 2025, when nearly a third of the health tech and distribution group fell more than 25%. Evolent Health (EVH): From ACA Headwinds to Specialty Care Expansion A day earlier on January 6, analysts at Citizens reiterated an Outperform rating on Evolent H ...